All In Biotech

Drug Trial Radar · NCT05673239

Effects of L-carnitine Therapy on the Heart of Maintenance Hemodialysis Patients

Effects of L-carnitine Therapy on the Heart of Maintenance Hemodialysis Patients: A Multicenter, Prospective, Non-randomized, Controlled Real-world Study

Last checked: Nov 19, 2026Latest source record: Aug 6, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

1,008

Actual

Start

Jan 15, 2023

Primary completion

Jun 30, 2023

Study completion Jun 30, 2024

Sponsor

Sponsor type
Academic, hospital or other
First posted
Jan 6, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is intended to be a multicenter, prospective, non-randomized, controlled real-world study. Patients receiving L-carnitine injection were included in the experimental group and the control group according to whether they received L-carnitine injection. Patients receiving L-carnitine injection were included in the experimental group, and those receiving L-carnitine injection were included in the control group.To observe the effects of L-carnitine on cardiac function in hemodialysis patients.

Conditions

  • Renal Dialysis

Interventions

  • Levocarnitine InjectionDrug

    The patients in the test group were injected with 1-2g (10-20mg/kg) levocarnitine on each dialysis day

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from baseline in Left ventricular ejection fractionTime frame: baseline and week 12

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • The First Affiliated Hospital of Zhejiang Chinese Medical University

    Hangzhou, Zhejiang, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.